Impact

Can Electric Health Records be used to predict the risk of mental health conditions?

5th September 2024

Researchers from our BRC Data Science Theme have contributed to an article on the use of Electronic Health Records (EHRs) to facilitate personalised treatments for psychiatric conditions. Clinical prediction models…

New drug to treat patients in the early stages of Alzheimer’s

23rd August 2024

This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of…

How can coping strategies prevent prolonged grief?

22nd August 2024

Research supported by University of Oxford’s Department of Experimental Psychology Prof. Anke Ehlers, Theme Lead of the BRC’s Psychological Treatments Theme, has found that the type of coping strategy used…

Big Health celebrates big approval

12th August 2024

A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…

New study – Serotonin changes how people learn and respond to negative information

9th August 2024

Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…

Could taking a specific anticonstipation drug reduce your risk of depression?

8th August 2024

In a new paper published today in BJPsych it is suggested that a specific anti constipation drug, prucalopride may reduce the risk of experiencing depression in individuals with no past…

Long-term cognitive and psychiatric effects of COVID-19 revealed in new study

1st August 2024

Many people who were hospitalised with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to a new study published today in Lancet Psychiatry….

New Online Therapies Bring Oxford Mental Health Research to NHS Patients

31st July 2024

Oxford University announces four new online therapies for anxiety and PTSD, now available on the NHS. The therapies target childhood anxiety and post-traumatic stress disorders and were developed with support form…

The DIME Study – Is a ketogenic diet beneficial for people with treatment-resistant depression?

29th July 2024

Researchers from the Biomedical Research Centre’s Preventing Multiple Morbidities Theme are looking into whether a ketogenic diet is an effective treatment for treatment-resistant depression (TRD). A ketogenic diet consists of…

Investigating the link between Alzheimer’s disease biomarkers and online testing for cognitive impairment

29th July 2024

A study into Alzheimer’s disease, completed by researchers in the BRC’s Dementia Theme, has found that data gathered from online cognition testing correlates to protein blood biomarker levels associated with…

New shingles vaccine could reduce risk of dementia – major study indicates

25th July 2024

The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine….

Does the programming of virtual reality (VR) characters impact VR treatments for paranoia?

25th July 2024

Researchers from the BRC’s Psychological Treatments Theme have contributed to a recent article on the programming characteristics of VR characters and their interpretations by people with paranoia. Paranoia, when a…

New study finds semaglutide safe for brain health with possible benefits for cognition and nicotine dependence

11th July 2024

Semaglutide – widely known as Ozempic/Wegovy – does not negatively impact brain health and is associated with lower risk of cognitive problems and less nicotine dependence, according to a new…

Can faith-based practice support treatment for poor mental health?

3rd July 2024

In his article for Lady Margaret Hall News, University of Oxford’s Department of Psychiatry DPhil candidate Gulamabbas Lakha speaks about his experiences with faith and the study of theology and…

OH BRC Brain Technologies Theme supports world’s first epilepsy device fitted into boy’s skull

27th June 2024

A study partnership involving University of Oxford researchers from the OH BRC’s Brain Technologies Theme, Great Ormond Street Hospital, University College London and King’s College Hospital were recently involved in…

Improving recovery for people with first episode psychosis

3rd June 2024

The NIHR Mental Health Translational Research Collaboration (MH-TRC) is a UK-wide network currently comprising eighteen centres of excellence. The MH-TRC delivers the NIHR and Office for Life Science (OLS) Mental…

Is there a link between short sleep duration in childhood and the development of psychosis in young adulthood?

28th May 2024

The Mental Health Mission Midlands Translational Centre (MH-MTC) is one of two demonstrator sites for the NIHR/OLS Mental Health Mission whose aim is to accelerate regional mental health research capacity…

AI to help personalise treatment for depression in Oxfordshire as part of major trial

13th May 2024

People with depression are being invited to be part of a clinical trial testing a new evidence-based AI treatment tool to personalise antidepressant treatment. The revolutionary digital tool, called PETRUSHKA,…

Blood tests for diagnosing dementia a step closer

4th April 2024

The University of Oxford and Oxford Health Clinical Research Facility is part of country-wide trials to identify accurate and quick blood tests that can diagnose dementia. World-class research teams at Dementias…

The UK Spring Clock Change: Navigating the Impact on Sleep

15th March 2024

World Sleep Day 2024 is celebrated on 15 March and this year’s theme is “Sleep Equity for Global Health”. Sleep is vital for good health, but there are significant disparities…

News

Impact

Footer

Improving brain health: the future in mind

Follow us